Oruka Therapeutics, Inc. /
ARCA
Oruka Therapeutics and ARCA biopharma merger proceeds under agreement




What happened
Oruka Therapeutics, Inc. and ARCA biopharma, Inc. are parties to a merger agreement dated April 3, 2024. ARCA announced an update to its special cash dividend, which will be $1.613 per share and payable Aug. 28, 2024.
The source
Everything on this page comes from the source below.
Oruka Therapeutics and ARCA biopharma merger proceeds under agreement
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verifiedAlso stated
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly